Skip to search formSkip to main contentSkip to account menu

Citalopram hydrobromide

Known as: (![PLUS-MINUS SIGN]!)-1-(3-dimethylaminopropyl)-1- (4-fluorophenyl)-1,3 dihydroisobenzofuran-5-carbonitrile, HBr, (±)-1-(3-dimethylaminopropyl)-1- (4-fluorophenyl)-1,3 dihydroisobenzofuran-5-carbonitrile, HBr, 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Monohydrobromide 
The orally bioavailable hydrobromide salt of the racemic bicyclic phthalene derivative citalopram with antidepressant activity. As a selective… 
National Institutes of Health

Related topics

Related topics

12 relations
Alcoholic Intoxication, ChronicCelexaCitalopram 20 MG Oral TabletCitalopram 40 MG Oral Tablet [Celexa]

Broader (1)

Citalopram

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
CONTEXT The corticotropin-releasing factor (CRF, or corticotropin-releasing hormone) and arginine vasopressin systems have been… 
Highly Cited
2009
Highly Cited
2009
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
CONTEXT Selective serotonin reuptake inhibitors are widely prescribed for children with autism spectrum disorders. OBJECTIVES… 
Highly Cited
2008
Highly Cited
2008
A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer.
OBJECTIVE To determine whether prophylactic treatment with the antidepressant citalopram hydrobromide, compared with placebo… 
Highly Cited
2008
Highly Cited
2008
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
CONTEXT Little is known about selecting among second-step medications for major depressive disorder after intolerance or lack of… 
2008
2008
CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus
Highly Cited
2007
Highly Cited
2007
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
CONTEXT A small subset of patients with depression exhibit new or worsening suicidal thoughts or behavior during short-term… 
Highly Cited
2006
Highly Cited
2006
Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
OBJECTIVE To compare the prevalence and clinical characteristics of neonatal abstinence syndrome in neonates exposed and not… 
2005
2005
The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive–aggressive dog, as measured with 123I-5-I-R91150 SPECT
PurposeInvolvement of the serotonergic system in impulsive aggression has been demonstrated in both human and animal studies. The… 
Highly Cited
2004
Highly Cited
2004
Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram
The effects in rats of long-term administration of the potent, specific 5-HT uptake inhibitor citalopram have been investigated… 
1999
1999
Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters.
The aims of this study were to characterize the recently cloned rat norepinephrine transporter (NET) in more detail and in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)